Bupropion hydrobromide not checked

Bausch Health Americas, Inc.

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 4 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
Aminoketone FDA class
Tested for
Major Depressive Disorder
Main trialPhase 4
“Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety”In the company’s words, NCT02129751 on ClinicalTrials.gov
Other names
Aplenzin

Other drugs for Major Depressive Disorder

All 36 drugs for Major Depressive Disorder

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 4Not yet recruiting Jul 2030 Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Bupropion hydrobromide

Following is part of Solo: you see every change to Bupropion hydrobromide the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in